Danel Pharma Limited
Registered number: 15456537
Balance Sheet
as at 31 January 2025
2025
£
Current assets
Cash at bank and in hand 100
100
Capital and reserves
Called up share capital 100
Profit and loss account -
Shareholder's funds 100
The director is satisfied that the company is entitled to exemption from the requirement to obtain an audit under section 480 of the Companies Act 2006 relating to dormant companies.
The member has not required the company to obtain an audit in accordance with section 476 of the Act.
The director acknowledges his responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.
The accounts have been prepared and delivered in accordance with the special provisions applicable to companies subject to the small companies regime. A profit and loss account has not been delivered to the Registrar of Companies.
David Freedman
Director
Approved by the board on 14 April 2025
Danel Pharma Limited
Notes to the Accounts
for the period from 31 January 2024 to 31 January 2025
1 Accounting policies
The accounts have been prepared under the historical cost convention.
2 Controlling party
The controlling party is David Freedman who owns the entire share capital of the company.
3 Other information
Danel Pharma Limited is a private company limited by shares and incorporated in England. Its registered office is:
9 Park Place
Newdigate Road
Harefield
Uxbridge
UB9 6EJ
Danel Pharma Limited 15456537 true 2024-01-31 2025-01-31 2025-01-31 VT Final Accounts April 2025 David Freedman No description of principal activity 15456537 2024-01-31 2025-01-31 15456537 bus:EntityHasNeverTraded 2024-01-31 2025-01-31 15456537 bus:PrivateLimitedCompanyLtd 2024-01-31 2025-01-31 15456537 bus:AuditExemptWithAccountantsReport 2024-01-31 2025-01-31 15456537 bus:Director40 2024-01-31 2025-01-31 15456537 countries:England 2024-01-31 2025-01-31 15456537 bus:FRS102 2024-01-31 2025-01-31 15456537 bus:FilletedAccounts 2024-01-31 2025-01-31 15456537 2025-01-31 15456537 core:ShareCapital 2025-01-31 15456537 core:RetainedEarningsAccumulatedLosses 2025-01-31 15456537 2024-01-30 iso4217:GBP